13 Nov 2014
Listing of ISEC Healthcare Ltd.
Rajah & Tann Singapore LLP ("R&T Singapore") was the legal adviser to ISEC Healthcare Ltd. ("Company") as to Singapore law in respect of its initial public offering and listing on Catalist, the sponsor-supervised listing platform of the Singapore Exchange Securities Trading Limited. The Company issued 70,000,000 new shares to investors in Singapore and Malaysia. The market capitalisation of the Company at listing (based on the placement price) was S$128.38 million. PrimePartners Corporate Finance Pte. Ltd. was the Issue Manager and Sponsor and Maybank Kim Eng Securities Pte. Ltd. was the Placement Agent.
ISEC Healthcare Ltd. is a comprehensive eye care service provider with ambulatory surgical centres in Malaysia and Singapore, having a team of 19 full-time specialist doctors practising at four locations. The Company's doctors are specialised in the fields of cataract and refractive surgery (including LASIK), vitreoretinal diseases, corneal and external eye diseases, glaucoma, uveitis, oculoplastics, facial cosmetics and aesthetics surgery as well as adult strabismus and paediatric ophthalmology.
Partners Evelyn Wee and Teo Yi Jing led the Capital Markets team from R&T Singapore, assisted by lawyers Hoon Chi Tern, Caitlin Huang and Esther Cher.
Partner Christopher Lee of Christopher & Lee Ong, assisted by lawyers Danny Foo and Nur Ayuni Binti Rahim, advised on the Malaysian law aspects of the transaction.